Welcure Drugs Jumps 53% Before 1:10 Bonus & Stock Split
New Delhi, Oct 14, 2025: The shares of Welcure Drugs & Pharmaceuticals Ltd (BSE: 524661) continued their purple patch on the stock exchanges as it surged by 4.97% on Tuesday before closing at ₹8.45 per share. After today’s surge, the stock has rallied by nearly 54% (53.60%) in the past two weeks, ahead of its upcoming corporate actions, which include a bonus issue and a stock split. The corporate actions are scheduled later this week.
The stock opened high and soon reached the day’s high (₹8.45 per share) and the upper circuit. The share stayed there until the closing bell. The counter has been placed under ASM Stage 1 surveillance, indicating elevated investor activity.
Welcure Drugs & Pharmaceuticals Ltd, engaged in the manufacturing and marketing of pharmaceutical formulations, is listed on the BSE under the Pharmaceuticals category. The company focuses on producing a range of therapeutic drugs catering to both domestic and export markets.
Recent Share Price Movement
The stock opened higher at ₹8.45, compared to its previous close of ₹8.05, and traded within a narrow intraday range of ₹8.45–₹8.25. With a market capitalization of ₹95.07 crore, the stock’s EPS (TTM) stands at ₹2.50, and it currently trades at a P/E ratio of 3.38, reflecting an attractive valuation. The ROE and PB ratios are 27.59% and 0.93, respectively, indicating healthy profitability and fair valuation.
In terms of performance, the stock has shown remarkable short-term momentum, gaining 27.26% in one week and 53.64% in two weeks. However, it saw a mild correction of 4.3% over the past month. Over longer periods, it has delivered strong returns of 8.75% in six months, 9.88% in one year, 118.91% in two years, and a massive 314.22% over five years, highlighting its sustained long-term growth potential.
Corporate Action Update
The bonus issue is scheduled in a 1:10 ratio, and a stock split from ₹10 to ₹1 face value is effective October 16, 2025 (record and effective dates). The no-delivery period starts from October 14 to October 16, 2025.
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
